Philip Norris

Philip Norris

Auto-generated profile, based on publicly available information

Philip Norris

School of Nursing and Midwifery University of Southern Queensland Toowoomba Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in International Journal of Surgery
Verified
Journal Article
Open access
PNPhilip Norris
Philip Norris
JGJeff Gow
Jeff Gow
TAThomas Arthur
Thomas Arthur
ACAaron Conway
Aaron Conway
FFFergal Fleming
Fergal Fleming
NRNicholas PhD Ralph
Nicholas PhD Ralph
Background: Metabolic syndrome (MetS) is characterised by the presence of at least three of the five following components: insulin resistance, obesity, chronic hypertension, elevated serum triglycerides, and decreased high-density lipoprotein cholesterol concentrations. It is estimated to affect 1 in 3 people around the globe and is reported to affect 46% of surgical patients. For people with MetS who undergo surgery, an emerging body of literature points to significantly poorer postoperative outcomes compared with nonaffected populations. The aim of this study is to review the current evidence on the risks of surgical complications in patients with MetS compared to those without MetS. Methods: Systematic review and meta-analysis using PRISMA and AMSTAR reporting guidelines. Results: The meta-analysis included 63 studies involving 1 919 347 patients with MetS and 11 248 114 patients without MetS. Compared to individuals without the condition, individuals with MetS were at an increased risk of mortality (OR 1.75 95% CI: 1.36–2.24; P<0.01); all surgical site infection types as well as dehiscence (OR 1.64 95% CI: 1.52–1.77; P<0.01); cardiovascular complications (OR 1.56 95% CI: 1.41–1.73; P<0.01) including myocardial infarction, stroke, cardiac arrest, cardiac arrythmias and deep vein thrombosis; increased length of hospital stay (MD 0.65 95% CI: 0.39–0.9; P<0.01); and hospital readmission (OR 1.55 95% CI: 1.41–1.71; P<0.01). Conclusion: MetS is associated with a significantly increased risk of surgical complications including mortality, surgical site infection, cardiovascular complications, increased length of stay, and hospital readmission. Despite these risks and the high prevalence of MetS in surgical populations there is a lack of evidence on interventions for reducing surgical complications in patients with MetS. The authors suggest prioritising interventions across the surgical continuum that include (1) preoperative screening for MetS; (2) surgical prehabilitation; (3) intraoperative monitoring and management; and (4) postoperative rehabilitation and follow-up.

17 June 2017 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
PNPhilip Norris
Philip Norris
NRNicholas Ralph
Nicholas Ralph
Clint MoloneyClint Moloney
Clint Moloney
Metabolic syndrome (MetS) is defined by an accumulation of risk factors that include cardiovascular disease, diabetes, chronic high blood pressure, obesity, and hypercholesterolaemia which results in an increased risk of developing serious chronic diseases. MetS is widespread as it is estimated to affect up to 30% of the global population. For people with MetS who undergo surgery, an emerging body of literature points to significantly poorer postoperative outcomes compared with non-affected populations. Surgical patients with MetS are at significantly higher risk of a range of adverse outcomes including death, morbid cardiovascular events, coma, stroke, renal failure, myocardial infarction, and surgical site infections. Increased complication rates result in prolonged hospital stays, a greater need for post-hospitalisation care, and reduced effectiveness of surgical interventions. We will search the following electronic bibliographic databases: MEDLINE, EMBASE, ScienceDirect, and CINAHL, and the reference lists of included articles. We will also search for unpublished literature. Two authors will screen titles and abstract information independently and select studies according to established inclusion and exclusion criteria. Data will be extracted by the study investigators using Review Manager 5 and will include information on demographics, incidence, prevalence, and outcome variables. Subgroup analysis and sensitivity analysis will be performed to assess the heterogeneity of included studies. Meta-analysis will also be carried out if appropriate study groups are identified. A descriptive narrative for statistical data will also be provided to highlight findings of the systematic review and meta-analysis. This study will report and summarise adverse outcomes among adult patients with MetS undergoing surgery across a range of surgical specialties. Developing insights into outcomes of this population of interest is necessary to develop guidelines towards better management of surgical patients with metabolic syndrome. PROSPERO CRD42016051071

6 December 2019 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
PNPhilip Norris
Philip Norris
BVBianca Viljoen
Bianca Viljoen
NRNicholas Ralph
Nicholas Ralph
JGJeff Gow
Jeff Gow
NSNatalie Silvey
Natalie Silvey
Metabolic syndrome (MetS) is defined as an accumulation of risk factors that include chronic hypertension, dyslipidaemia, insulin resistance and obesity and leads to an increased risk for diabetes, cardiovascular disease and stroke. MetS is widespread and estimated to affect up to a quarter of the global population. Patients with MetS who undergo surgery are associated with an increased risk of postoperative complications when compared with patients with a non-MetS profile. An emerging body of literature points to MetS being associated with a greater risk of postoperative pulmonary complications (PPC) in the surgical patient. PPC are associated with increased postoperative morbidity and mortality, Intensive care unit (ICU) admission, length of stay (ICU and hospital), health care costs, resource usage, unplanned re-intubation and prolonged ventilatory time. We will search for relevant studies in the following electronic bibliographic databases: EMBASE, MEDLINE, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Scopus as well as scan the reference lists of included studies for potential additional literature. Two authors will independently screen titles and abstracts to identify potentially relevant studies for inclusion based on predefined inclusion and exclusion criteria. The Cochrane Collaboration Review Manager (Review Manager 5) statistical software will be used to conduct this systematic review and meta-analysis and generate forest plots to demonstrate comparison of findings across studies included for meta-analysis. Subgroup and sensitivity analysis will be performed to assess the heterogeneity of included studies. A descriptive synthesis of the statistical data will be provided to summarise the results and findings of the systematic review and meta-analysis. This review will be the first to report and summarise the risk for and incidence of PPC in adult patients with MetS undergoing surgery across a range of surgical specialities. The results have the potential to inform the development of evidenced-based interventions to improve the management of PPC in the surgical patient with MetS. Findings from this systematic review and meta-analysis will inform a subsequent Delphi study on priorities and responses to PPC in patients with MetS. We will also disseminate our results through publication in scientific peer-reviewed journals, conference presentations and promotion throughout our network of surgical safety champions in clinical settings. PROSPERO CRD42019120279 .

20 March 2026 in Anz Journal of Surgery
Verified
Journal Article
Open access
PNPhilip Norris
Philip Norris
JGJeff Gow
Jeff Gow
TAThomas Arthur
Thomas Arthur
DRDaevyd Rodda
Daevyd Rodda
JCJoseph Coory
Joseph Coory
NRNicholas Ralph
Nicholas Ralph
Background: Metabolic syndrome (MetS) is common in elective surgical populations and is associated with increased postoperative complications. The national economic burden of MetS‐attributable surgical morbidity in Australia has not been quantified. Methods: A prevalence‐based cost‐of‐illness model was constructed using Australian elective surgery volume data from the Australian Institute of Health and Welfare (2.3 million admissions, 2021–2022). MetS prevalence was modelled at 35% (sensitivity range 25%–46%). Complication risks were derived from a systematic review and meta‐analysis of over 13 million surgical patients. Excess direct hospital costs were estimated from an Australian public hospital system perspective for surgical site infections, cardiovascular events, 30‐day readmissions, and extended length of stay. Unit costs were obtained from the National Hospital Cost Data Collection and the Independent Hospital Pricing Authority, reported in 2023 Australian dollars. Deterministic sensitivity analysis tested model robustness. Results: The annual cost burden attributable to MetS was AUD 1.98 billion (95% CI: AUD 1.32–2.64 billion). Costs were driven primarily by extended length of stay (AUD 1.15 billion), followed by readmissions (AUD 345 million), cardiovascular events (AUD 243 million), and surgical site infections (AUD 242 million). Costs ranged from AUD 1.32 billion at 25% prevalence to AUD 2.64 billion at 46% prevalence. The mean additional cost per MetS surgical patient was AUD 2460. Conclusion: MetS imposes a substantial direct hospital cost burden on the Australian public hospital system. These findings support evaluation of routine preoperative MetS screening and optimisation strategies.

8 June 2026 in Anz Journal of Surgery
Verified
Journal Article
Open access
PNPhilip Norris
Philip Norris
JGJeff Gow
Jeff Gow
TAThomas Arthur
Thomas Arthur
DRDaevyd Rodda
Daevyd Rodda
JCJoseph Coory
Joseph Coory
NRNicholas Ralph
Nicholas Ralph
Background: Metabolic syndrome (MetS) is a cluster of risk factors, including cardiovascular disease, diabetes, chronic hypertension, obesity, and hypercholesterolemia, which collectively increase the risk of chronic diseases and adverse health outcomes. Affecting up to 30% of the global population, MetS poses significant challenges for surgical patients, with emerging evidence indicating poorer postoperative outcomes compared to nonaffected populations. Despite its growing prevalence, there is a lack of dedicated interventions to address the specific needs of this group. This study aims to explore the barriers and facilitators influencing the management of MetS in surgical patients, with the goal of informing intervention development. Methods: A qualitative, exploratory study was conducted using the Theoretical Domains Framework (TDF) to guide data collection and analysis. Semi‐structured interviews were conducted with clinicians involved in the perioperative care of patients with MetS, focusing on their perspectives on barriers and facilitators to effective management. Data were analyzed thematically and mapped to the 14 TDF domains. Results: Clinicians identified significant barriers, including resource constraints, fragmented care pathways, and variability in team roles. Facilitators included peer validation, multidisciplinary collaboration, and the integration of decision‐support tools. Emotional and motivational factors also emerged as critical determinants of engagement. Conclusion: This study underscores the need for targeted interventions to address the unique challenges of managing MetS in surgical contexts. The findings provide a foundation for developing behaviorally informed frameworks, with implications for improving surgical outcomes and reducing healthcare costs.